These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 320990)

  • 21. Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic.
    Derom EY; Pauwels RA
    Thorax; 1992 Jan; 47(1):30-3. PubMed ID: 1539141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term evaluation of a new aerosol bronchodilator, carbuterol, and comparison with isoproterenol.
    Drachler DH; Bower JS; Miller DA; Rotman HH
    J Clin Pharmacol; 1977; 17(11-12):734-9. PubMed ID: 336653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Double blind trial of hexoprenaline as a bronchodilator].
    Ulmer WT
    Arzneimittelforschung; 1974 May; 24(5):840-1. PubMed ID: 4603484
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of the bronchodilator action of fenoterol and salbutamol by aerosol administration in patients with bronchial asthma].
    Todisco T; Ansidei V; Miele N; Porcellati C; Sorbini CA
    Minerva Med; 1975 Dec; 66(84):4535-45. PubMed ID: 1202407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of airway obstruction on albuterol-mediated variations in the resistive and elastic properties of the respiratory system of patients with asthma.
    Veiga J; Lopes AJ; Jansen JM; de Melo PL
    J Bras Pneumol; 2009 Jul; 35(7):645-52. PubMed ID: 19669002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study between procaterol and salbutamol in mild to moderate bronchial asthma].
    Legris C; Boulet LP; Lafrance L; Bélanger J; Beaupré A
    Therapie; 1987; 42(2):213-6. PubMed ID: 2956725
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of oral bronchodilator therapy as shown by a comparison between salbutamol and terbutaline.
    Cochrane GM; Clark TJ; Hanan ME
    Curr Med Res Opin; 1973; 1(9):517-23. PubMed ID: 4591820
    [No Abstract]   [Full Text] [Related]  

  • 29. A trial of clenbuterol in bronchial asthma.
    Anderson G; Wilkins E
    Thorax; 1977 Dec; 32(6):717-9. PubMed ID: 341407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma.
    Kruse M; Rosenkranz B; Dobson C; Ayre G; Horowitz A
    Pulm Pharmacol Ther; 2005; 18(3):229-34. PubMed ID: 15707858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients.
    Tamagaki G; Kanazawa H; Hirata K
    Pulm Pharmacol Ther; 2012 Dec; 25(6):478-82. PubMed ID: 22982562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.
    Cockcroft DW; Donevan RE; Copland GM
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):170-9. PubMed ID: 813954
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of carbuterol and salbutamol from metered aerosols in bronchial asthma.
    Beumer HM; Mills JG; Sharpe PC
    Respiration; 1978; 35(4):220-3. PubMed ID: 345380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical pharmacology of a new specific adrenergic beta bronchodilator].
    Curti PC
    Int J Clin Pharmacol; 1974 Jun; 9(4):305-13. PubMed ID: 4153546
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative trial of a new anticholinergic bronchodilator, Sch 1000, and salbutamol in chronic bronchitis.
    Poppius H; Salorinne Y
    Br Med J; 1973 Oct; 4(5885):134-6. PubMed ID: 4584707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spirometric comparison of carbuterol and salbutamol oral therapy in reversible obstructive airway disease.
    Kulpati DD; Bogra KC; Kinra V; Datta TK
    Indian J Chest Dis Allied Sci; 1980; 22(3):158-65. PubMed ID: 7011953
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical trial of long-term oral salbutamol in reversible diffuse airway obstruction.
    Epstein SW; Barnard JA; Zsotér TT
    Am Rev Respir Dis; 1973 Dec; 108(6):1367-72. PubMed ID: 4584563
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the duration of action of fenoterol and salbutamol in asthma.
    Lawford P; Dowd DE; Palmer KN
    Curr Med Res Opin; 1981; 7(6):349-51. PubMed ID: 7016447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.